Abstract
Falcipain-2 (FP2) is an essential enzyme in the lifecycle of malaria parasites such as Plasmodium falciparum, and its inhibition is viewed as an attractive mechanism of action for new anti-malarial agents. Selective inhibition of FP2 with respect to a family of human cysteine proteases (that include cathepsins B, K, L and S) is likely to be required for the development of agents targeting FP2. Here we describe a series of P2-modified aminonitrile based inhibitors of FP2 that provide a clear strategy toward addressing selectivity for the P. falciparum and show that it can provide potent FP2 inhibitors with strong selectivity against all four of these human cathepsin isoforms.
Keywords:
3-Pyridine; Falcipain-2 Peptidomimetic-nitrile; Malaria; Selective.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antimalarials / chemical synthesis
-
Antimalarials / chemistry
-
Antimalarials / pharmacology*
-
Cathepsins / antagonists & inhibitors*
-
Cathepsins / metabolism
-
Cysteine Endopeptidases / metabolism*
-
Cysteine Proteinase Inhibitors / chemical synthesis
-
Cysteine Proteinase Inhibitors / chemistry
-
Cysteine Proteinase Inhibitors / pharmacology*
-
Dose-Response Relationship, Drug
-
Humans
-
Malaria, Falciparum / drug therapy
-
Malaria, Falciparum / metabolism
-
Molecular Structure
-
Nitriles / chemical synthesis
-
Nitriles / chemistry
-
Nitriles / pharmacology*
-
Peptidomimetics / chemical synthesis
-
Peptidomimetics / chemistry
-
Peptidomimetics / pharmacology*
-
Structure-Activity Relationship
Substances
-
Antimalarials
-
Cysteine Proteinase Inhibitors
-
Nitriles
-
Peptidomimetics
-
Cathepsins
-
Cysteine Endopeptidases
-
falcipain 2